A successful acquisition strategy goes beyond the highest bid. It involves 'thinking like the molecule'—evaluating which buyer has the specific expertise, capabilities, and cultural alignment to best steward the asset's development. This reframes M&A from a financial transaction to a decision about the asset's future.

The most critical lesson from integrating 22 acquisitions wasn't about perfecting data migration. Instead, success was determined by spending significant time with acquired teams *before* migrating core systems. This human-centric approach ensures teams feel supported and bought into the new direction, which is more impactful than technical flawlessness.

Successful large-scale acquirers remain nimble, flexing their own processes to suit the acquired company rather than force-fitting it into a rigid corporate structure. This preserves the culture and talent that made the company valuable, preventing value destruction and keeping the new team engaged.

When integrating acquired biotechs, Merck prioritizes retaining key talent and preserving ongoing science. The strategy involves immediate face-to-face engagement to reduce anxiety, followed by a pragmatic assessment of which processes must be standardized versus which can remain to avoid disrupting critical trials, a practice they call avoiding 'mercification'.

To avoid cultural dilution post-acquisition, the smaller company can maintain its identity by operating as a separate business entity within the larger organization. This allows them to preserve unique operational cadences and internal collaboration models, like Splunk's 'village' approach, amidst the broader integration process.

In people-based industries, an acquirer's culture is a key differentiator. Founders of target firms will often choose a buyer with a reputation for valuing employees over a higher bid from a private equity firm known for cost-cutting, making culture a tangible competitive M&A advantage.

A one-size-fits-all integration can destroy the culture that made an acquisition valuable. When State Street acquired software firm CRD, it intentionally broke from its standard process, allowing CRD to keep its brand identity, facilities, and even email domain to preserve its creative culture and retain key talent.

Unlike typical pharma M&A where acquired executives depart, Eli Lilly retains and promotes talent from companies it buys, such as Jake Van Narden from Loxo Oncology. This tech-industry style "acqui-hire" strategy helps Lilly absorb entrepreneurial talent and institutional knowledge, embedding innovation directly into its senior leadership ranks.

For iCapital, an acquisition is not complete until both the technology and the people are fully integrated into a "one-eye capital" culture. The CEO emphasizes that people integration is even more critical than tech integration, as a failure on the cultural front means the entire acquisition fails.